Page last updated: 2024-11-03

riluzole and Angiogenesis, Pathologic

riluzole has been researched along with Angiogenesis, Pathologic in 2 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhu, Y1
Gao, M1
Zhou, T1
Xie, M1
Mao, A1
Feng, L1
Yao, X1
Wong, WT1
Ma, X1
Wen, Y1
Li, J1
Koo, J1
Shin, SS1
Lin, Y1
Jeong, BS1
Mehnert, JM1
Chen, S1
Cohen-Sola, KA1
Goydos, JS1

Other Studies

2 other studies available for riluzole and Angiogenesis, Pathologic

ArticleYear
The TRPC5 channel regulates angiogenesis and promotes recovery from ischemic injury in mice.
    The Journal of biological chemistry, 2019, 01-04, Volume: 294, Issue:1

    Topics: Animals; Disease Models, Animal; Endothelial Cells; HEK293 Cells; Humans; Ischemia; Mice; Mice, Knoc

2019
Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression.
    Cancer research, 2014, May-01, Volume: 74, Issue:9

    Topics: Angiogenesis Inhibitors; Animals; Cell Movement; Heterocyclic Compounds, 3-Ring; Humans; Hypoxia-Ind

2014